Centrally administered oligodeoxynucleotides in rats: Occurrence of non-specific effects

European Journal of Pharmacology

Volumn 331, Issue 2-3, 1997, Pages 97-107

  Schöbitz, Bernd ^a   Pezeshki, Gita ^a   Probst, Joseph Christopher ^a   Reul, Johannes M H M ^a   Skutella, Thomas ^a   Stöhr, Thomas ^a   Holsboer, Florian ^a   Spanagel, Rainer ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antisense targeting; Interleukin 6; Oligodeoxynucleotides; Radiotelemetry; Rat; Sickness behavior

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CORTICOSTERONE; INTERLEUKIN 6; OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG EFFECT; FEVER; FLUID INTAKE; FOOD INTAKE; ILLNESS BEHAVIOR; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; TELEMETRY;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, NORTHERN; BODY TEMPERATURE; CORTICOSTERONE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; ENDOTOXINS; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-6; MALE; MOTOR ACTIVITY; OLIGONUCLEOTIDES; RATS; RATS, WISTAR;

EID: 0343487713     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01014-5     Document Type: Article

References (36)

1. Akhtar, S., Juliano, R.L., 1992. Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell Biol. 2, 139-144.
2. Bennett, R., Gabor, G., Merritt, M., 1985. DNA binding to human leukocytes. J. Clin. Invest. 76, 2182-2190.
3. Chomczynski, P., Sacchi, N., 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
4. Crooke, R.M., 1991. In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Anticancer Drug Des. 6, 609-646.
5. Crooke, S.T., 1992. Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32, 329-376.
6. Damas, P., Ledoux, D., Nys, M., Vrindts, Y., de Groote, D., Franchimont, P., Lamy, M., 1991. Cytokine serum level during severe sepsis in human interleukin-6 as a marker of severity. Ann. Surg. 215, 356-362.
7. Di Padova, F., Pozzi, C., Tondre, M.J., Tritapepe, R., 1991. Selective and early increase of interleukin-1 inhibitors, interleukin-6 and cortisol after surgery. J. Clin. Exp. Immunol. 85, 137-142.
8. Galbraith, W.M., Hobson, W.C., Giclas, P.C., Schechter, P.J., Agraval, S., 1994. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligodeoxynucleotides in the monkey. Antisense Res. Dev. 4, 201-207.
9. Hart, B. L, 1988. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12, 123-137.
10. Homma, J.Y., Kanegasaki, S., Luderitz, O., Shiba, T., Westphal, O., 1984. Bacterial Endotoxin: Chemical, Biological and Clinical Aspects. Verlag Chemie, Basel, Switzerland.
11. Lindsay, H.L., Trown, P.W., Brandt, J., Forbes, M., 1969. Pyrogenicity of polyI:C. Nature 223, 717-718.
12. Lynn, W.A., Golenbock, D.T., 1992. Lipopolysaccharide antagonists. Immunol. Today 13, 271-276.
13. Morrison, D.C., Curry, B.J., 1979. The use of polymyxin B and C3H/HeJ mouse spleen cells as criteria for endotoxin contamination. J. Immunol. Methods 27, 83-92.
14. Muramami, N., Fukata, J., Tsukada, T., Kobayashi, H., Ebisui, O., Segawa, H., Muro, S., Imura, H., Nakao, K., 1993. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology 133, 2574-2578.
15. Neckers, L., Whitesell, L., 1993. Antisense technology: Biological utility and practical considerations. Am. J. Physiol. 265, L1-L12.
16. Neumann, I., Porter, D.W.F., Landgraf, R., Pittman, Q.J., 1994. Rapid effect on suckling of an oxytocin antisense oligonucleotide administered into rat supraoptic nucleus. Am. J. Physiol. 267, R852-R858.
17. Nijsten, M.W.N., de Groot, E.R., ten Duis, H.J., Klasen, H.J., Hack, C.E., Aarden, L.A., 1987. Serum levels of interleukin-6 and acute phase response. Lancet 2, 921-927.
18. Northemann, W., Braciak, T.A., Hattori, M., Lee, F., Fey, G.H., 1989. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J. Biol. Chem. 264, 16072-16082.
19. Ortigao, J.F.R., Rösch, H., Selter, H., Fröhlich, A., Lorenz, A., Montenarh, M., Seliger, H., 1992. Antisense effect of oligodeoxynucleotides with inverted terminal internucleotidic linkages: A minimal modification protecting against nucleolytic degradation. Antisense Res. Dev. 2, 129-146.
20. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, London.
21. Perez, J.R., Li, Y., Stein, C.A., Majumder, S., van Oorschot, A., Narayanan, R., 1994. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 91, 5957-5961.
22. Perry, V.H., Andersson, P.B., 1992. The inflammatory response in the CNS. Neuropathol. Appl. Neurobiol. 18, 454-459.
23. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning, a Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Sarmiento, U.M., Perez, J.R., Becker, J.M., Narayanan, R., 1994. In vivo toxicological effects of rel A antisense phosphorotioates in CD-1 mice. Antisense Res. Dev. 4, 99-107.
25. Schöbitz, B., de Kloet, E.R., Sutanto, W., Holsboer, F., 1993. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5, 1426-1435.
26. Schöbitz, B., de Kloet, E.R., Holsboer, F., 1994a. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44, 397-432.
27. Schöbitz, B., Holsboer, F., de Kloet, E.R., 1994b. Cytokines in the healthy and diseased brain. News Physiol. Sci. 9, 138-142.
28. Shimizu, T., Wolfe, L.S., 1990. Arachidonic acid cascade and signal transduction. J. Neurochem. 55, 1-15.
29. Skutella, T., Probst, J.C., Engelmann, M., Wotjak, C.T., Landgraf, R., Jirikowski, G.F., 1994. Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats. J. Neuroendocrinology 6, 121-126.
30. Smith, W. L, 1989. The eicosanoids and their biochemical mechanism of action. Biochem. J. 259, 315-324.
31. Stein, C.A., Cheng, Y.C., 1993. Antisense oligonucleotides as therapeutic agents: Is the bullet really magical?. Science 261, 1004-1012.
32. Stein, C.A., 1996. Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity. Trends Biotechnol. 14, 147-152.
33. Uhlmann, E., Peyman, A., 1990. Antisense oligonucleotides: A new therapeutic principle. Chem. Rev. 4, 543-584.
34. Wahlestedt, C., 1994. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15, 42-46.
35. Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J.R., Neckers, L.M., 1993. Stability clearance, and disposition of intracerebroventricularly administered oligodeoxynucleotides: Implications for therapeutic application within the central nervous system. Proc. Natl. Acad. Sci. USA 90, 4665-4669.
36. Yakubov, L.A., Deeva, E.A., Zarytova, V.F., Ivanova, E.M., Ryte, A.S., Yurchenko, L.V., Vlassov, V.V., 1989. Mechanisms of oligonucleotide uptake by cells: Involvement of specific receptors?. Proc. Natl. Acad. Sci. USA 86, 6454-6458.